Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
/in Chronic Leukemia, Dendritic Cells, International PublicationsVaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsImmunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
/in Dendritic Cells, International PublicationsDendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
/in Dendritic Cells, Glioblastoma, International PublicationsNatural-killer cells and dendritic cells: „l’union fait la force“
/in Dendritic Cells, International PublicationsClinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International PublicationsChaperone-rich cell lysates, immune activation and tumor vaccination
/in Dendritic Cells, Hyperthermia, International PublicationsEmerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function
/in Dendritic Cells, Hyperthermia, International PublicationsMaturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity
/in Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer